A Study of the Effect of Nemtabrutinib (MK-1026) on the Plasma Levels of Digoxin in Healthy Participants (MK-1026-012)
Clinical trial NCT06625827 · COMPLETED
Trial details
- NCT number
- NCT06625827
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2024-01-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.